Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy. Blair AB, Wang J, Davelaar J, Baker A, et al. Gastroenterology 2022 Jun 16. pii: S0016-5085(22)00645.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blair AB, Wang J, Davelaar J, Baker A, et al. Dual stromal targeting sensitizes pancreatic adenocarcinoma for anti-PD-1 therapy. Gastroenterology 2022 Jun 16. pii: S0016-5085(22)00645.
PMID: 35718227